BOSTON and NEW YORK, June 23 /PRNewswire/ -- Constitution Medical
Investors, Inc. (CMI), a Boston-based private investment firm focused on
healthcare sector-related acquisitions and led by senior healthcare executives
Patrick Sullivan and Daniel Levangie, today announced its formation in
partnership with Warburg Pincus, the global private equity firm. Mr. Sullivan
is the former President and Chief Executive Officer of Cytyc Corporation and,
until recently, served as Executive Chairman of Hologic, Inc. (Nasdaq: HOLX),
which acquired Cytyc in October 2007. Mr. Levangie previously was Executive
Vice President of Cytyc Corporation and President of Cytyc's Surgical Products
Division. He currently serves as a director of Hologic, Inc.
Constitution Medical Investors will focus on the identification and
acquisition of innovative, healthcare-related platform technologies and
companies where the principals will be able to leverage their product
development, regulatory, clinical and commercial experience. Over the course
of 15 years at Cytyc, one of the leading companies focused on improving
healthcare for women, the CMI executive team helped grow the company to
approximately $700 million in annual revenues and establish operations in 20
countries.
"Having helped to build Cytyc Corporation to its preeminent position in
women's health, and with the integration of Cytyc with Hologic now complete,
we are excited to put our extensive experience to work in a new venture," said
Mr. Sullivan. "We are proud of our track record of success in creating value
in the healthcare marketplace, and we are very pleased to partner with Warburg
Pincus, which will provide us with world-class support and resources that will
allow us to once again make a real difference in improving medical care."
"Pat and I have enjoyed a symbiotic business relationship for more than 20
years. I can't think of a partnership with more potential than what we have
formed with CMI," said Mr. Levangie.
Bess Weatherman, the Warburg Pincus Managing Director who leads the firm's
investment activities in medical devices and healthcare services, said, "We
are very excited to join Pat and Dan in the formation of CMI, and are eager to
work with them in the identification of opportunities that will leverage their
deep experience and industry know-how."
Constitution Medical Investors is based in Boston, MA at: Boston
Independence Wharf, 470 Atlantic Avenue, 4th Floor. Boston, MA 02210.
617-273-8418.
About Constitution Medical Investors, Inc.
Constitution Medical Investors, Inc. is a Boston-based private investment
firm focused on healthcare sector-related acquisitions, and launched in
partnership with Warburg Pincus, the global private equity firm. CMI is led
by Patrick Sullivan, formerly President and Chief Executive Officer of Cytyc
Corporation and Executive Chairman of Hologic, Inc. (Nasdaq: HOLX), and Daniel
Levangie, formerly Executive Vice President of Cytyc Corporation and President
of Cytyc's Surgical Products Division. CMI focuses on the identification and
acquisition of innovative, healthcare-related platform technologies and
companies where the principals will be able to leverage their product
development, regulatory, clinical and commercial experience. For more
information, visit www.conmedinvestors.com.
About Warburg Pincus
Warburg Pincus has been a leading private equity investor since 1971. The
firm currently has more than $35 billion of assets under management. Warburg
Pincus' investments are focused on a range of sectors in North America, Europe
and Asia, including financial services, healthcare, industrial, technology,
media and telecommunications, energy, consumer and retail and real estate.
Since inception, the firm has raised 12 private equity funds that have
invested more than $31 billion in approximately 600 companies in more than 30
countries. The firm has invested $6.6 billion in healthcare-related companies
around the world, including approximately $1.6 billion to help build nearly 40
biotechnology and pharmaceutical companies. The firm has an active global
portfolio of more than 125 companies and offices in Beijing, Frankfurt, Hong
Kong, London, Mumbai, New York, San Francisco, Shanghai and Tokyo. For more
information, visit www.warburgpincus.com.
Business Inquiries:
Patrick Sullivan, Managing Partner
(978) 985-8504
patrick.sullivan@conmedinvestors.com
Daniel Levangie
Managing Partner
(617) 697-6070
dan.levangie@conmedinvestors.com
Media Inquiries:
Todd Fogarty or Joseph Kuo
Kekst and Company
212-521-4800
todd-fogarty@kekst.com or joe-kuo@kekst.com
SOURCE Constitution Medical Investors, Inc.